HIV :: Supercomputer Fights HIV and AIDS
IBM announced that the virtual supercomputer will test thousands of human immuno-deficiency virus (HIV) mutations against tens of thousands of chemical compounds.
Drug
Health :: Best Health Articles in October 2005
Following are the best health articles in October 2005, arranged as per viewed frequency:
Health :: Best Health Articles in September 2005
Following are the best health articles in September 2005, arranged as per viewed frequency:
Health :: Best Health Articles in August 2005
Following are the best health articles in August 2005, arranged as per viewed frequency:
Fibromyalgia :: Severe pain in left lower limb – Rhus Tox
Mrs. M.M. , 34 years consulted me on 19th April, 1971 for severe pain in her left lower limb. She had consulted the best available specialists for this ailment. But she could get little relief and now believed her disease to be incurable.
Health :: Sexual Disorders
Typically sexual disorders are disturbances in the sexual response, in a brief we have to understand the normal human sexual response cycle. This is divided into different phases
Breast Cancer :: Results from the NSABP Breast Cancer Prevention Trial
Researchers from the National Surgical Adjuvant Breast and Bowel Project (NSABP) who conducted the landmark Breast Cancer Prevention Trial (BCPT), report a seven-year and final update of the trial results in the November 16, 2005, Journal of the National Cancer Institute.
HIV :: Combination Microbicides Protect Against HIV-Like Virus
Experiments in female monkeys have for the first time shown that when used in combination, vaginal gels known as microbicides can protect against an HIV-like virus. The research, funded largely by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), suggests that similar combination microbicides could potentially provide a safe, effective and practical way to prevent HIV transmission to women, according to study investigators.
Pneumonia :: Lung Scarring Diseases Linked to Genes and Smoking
New research shows that idiopathic interstitial pneumonia (IIP), a group of potentially fatal disorders that affects the lungs, may be caused by an interaction between a specific genetic background and cigarette smoking. In a study of 111 families that had at least two relatives with IIP, people who smoked cigarettes were three times more likely than non-smokers to develop the disease. The research was supported by the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Environmental Health Sciences (NIEHS), both institutes within the National Institutes of Health.
Leukemia :: Arranon for Rare Leukemia and Lymphoma
The Food and Drug Administration (FDA) announced the approval of Arranon (nelarabine) for marketing in the United States. This is a new drug to treat adults and children with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL), whose disease has not responded to or has relapsed following at least two chemotherapy regimens. Arranon is the first drug to treat this limited population of patients.